Target Price | CHF717.00 |
Price | CHF803.00 |
Deviation | 10.71% |
Number of Estimates | 13 |
13 Analysts have issued a price target Swiss Life 2026 . The average Swiss Life target price is CHF717.00. This is 10.71% lower than the current stock price. The highest price target is CHF805.00 0.25% , the lowest is CHF575.00 28.39% . | |
A rating was issued by 16 analysts: 5 Analysts recommend Swiss Life to buy, 6 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Swiss Life stock has an average upside potential 2026 of 10.71% . Most analysts recommend the Swiss Life stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 15.28 | 20.48 |
0.27% | 34.03% | |
Net Margin | 7.92% | 6.21% |
13.94% | 21.59% |
4 Analysts have issued a sales forecast Swiss Life 2025 . The average Swiss Life sales estimate is CHF20.5b . This is 34.04% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.2b 38.52% , the lowest is CHF19.8b 29.87% .
This results in the following potential growth metrics:
2024 | CHF15.3b | 0.27% |
---|---|---|
2025 | CHF20.5b | 34.03% |
2026 | CHF20.8b | 1.53% |
2027 | CHF20.7b | 0.37% |
2028 | CHF21.0b | 1.44% |
9 Swiss Life Analysts have issued a net profit forecast 2025. The average Swiss Life net profit estimate is CHF1.3b . This is 5.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.4b 13.16% , the lowest is CHF1.2b 0.29% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.2b | 14.25% |
---|---|---|
2025 | CHF1.3b | 5.11% |
2026 | CHF1.4b | 6.41% |
2027 | CHF1.4b | 6.19% |
2028 | CHF1.5b | 7.17% |
2029 | CHF1.5b | 2.84% |
2024 | 7.92% | 13.94% |
---|---|---|
2025 | 6.21% | 21.59% |
2026 | 6.51% | 4.83% |
2027 | 6.94% | 6.61% |
2028 | 7.33% | 5.62% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 42.41 | 44.58 |
14.25% | 5.12% | |
P/E | 18.11 | |
EV/Sales | 1.57 |
9 Analysts have issued a Swiss Life forecast for earnings per share. The average Swiss Life EPS is CHF44.58 . This is 5.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF47.91 13.16% , the lowest is CHF42.46 0.28% .
This results in the following potential growth metrics and future valuations:
2024 | CHF42.41 | 14.25% |
---|---|---|
2025 | CHF44.58 | 5.12% |
2026 | CHF47.44 | 6.42% |
2027 | CHF50.37 | 6.18% |
2028 | CHF53.99 | 7.19% |
2029 | CHF52.45 | 2.85% |
Current | 18.91 | 11.04% |
---|---|---|
2025 | 18.11 | 4.23% |
2026 | 17.02 | 6.02% |
2027 | 16.03 | 5.82% |
2028 | 14.96 | 6.67% |
2029 | 15.39 | 2.87% |
Based on analysts' sales estimates for 2025, the Swiss Life stock is valued at an EV/Sales of 1.57 and an P/S ratio of 1.11 .
This results in the following potential growth metrics and future valuations:
Current | 2.10 | 2.78% |
---|---|---|
2025 | 1.57 | 25.27% |
2026 | 1.55 | 1.50% |
2027 | 1.55 | 0.37% |
2028 | 1.53 | 1.42% |
Current | 1.48 | 2.84% |
---|---|---|
2025 | 1.11 | 25.40% |
2026 | 1.09 | 1.50% |
2027 | 1.09 | 0.37% |
2028 | 1.08 | 1.42% |
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Dec 12 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Dec 08 2024 |
HSBC |
Hold
➜
Hold
|
Unchanged | Nov 24 2024 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Dec 12 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Dec 08 2024 |
Unchanged
HSBC:
Hold
➜
Hold
|
Nov 24 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.